These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

259 related items for PubMed ID: 9972966

  • 1. The cholesterol lowering effect of antimalarial drugs is enhanced in patients with lupus taking corticosteroid drugs.
    Rahman P, Gladman DD, Urowitz MB, Yuen K, Hallett D, Bruce IN.
    J Rheumatol; 1999 Feb; 26(2):325-30. PubMed ID: 9972966
    [Abstract] [Full Text] [Related]

  • 2. Lupus erythematosus tumidus: response to antimalarial treatment in 36 patients with emphasis on smoking.
    Kreuter A, Gaifullina R, Tigges C, Kirschke J, Altmeyer P, Gambichler T.
    Arch Dermatol; 2009 Mar; 145(3):244-8. PubMed ID: 19289751
    [Abstract] [Full Text] [Related]

  • 3. The relevance of antimalarial therapy with regard to thrombosis, hypercholesterolemia and cytokines in SLE.
    Wallace DJ, Linker-Israeli M, Metzger AL, Stecher VJ.
    Lupus; 1993 Feb; 2 Suppl 1():S13-5. PubMed ID: 8485565
    [Abstract] [Full Text] [Related]

  • 4. Discontinuation of antimalarial drugs in systemic lupus erythematosus.
    Wang C, Fortin PR, Li Y, Panaritis T, Gans M, Esdaile JM.
    J Rheumatol; 1999 Apr; 26(4):808-15. PubMed ID: 10229401
    [Abstract] [Full Text] [Related]

  • 5. Effect of antimalarial agents on the fasting lipid profile in systemic lupus erythematosus.
    Tam LS, Gladman DD, Hallett DC, Rahman P, Urowitz MB.
    J Rheumatol; 2000 Sep; 27(9):2142-5. PubMed ID: 10990225
    [Abstract] [Full Text] [Related]

  • 6. Antimalarials and cholesterol profile of patients with systemic lupus erythematosus.
    Rossoni C, Bisi MC, Keiserman MW, Staub HL.
    Rev Bras Reumatol; 2011 Sep; 51(4):383-4, 386-7. PubMed ID: 21779713
    [Abstract] [Full Text] [Related]

  • 7. The efficacy of antimalarials in systemic lupus erythematosus.
    Rudnicki RD, Gresham GE, Rothfield NF.
    J Rheumatol; 1975 Sep; 2(3):323-30. PubMed ID: 1102684
    [Abstract] [Full Text] [Related]

  • 8. Smoking interferes with efficacy of antimalarial therapy in cutaneous lupus.
    Rahman P, Gladman DD, Urowitz MB.
    J Rheumatol; 1998 Sep; 25(9):1716-9. PubMed ID: 9733451
    [Abstract] [Full Text] [Related]

  • 9. Longterm beneficial effect of chloroquine diphosphate on lipoprotein profile in lupus patients with and without steroid therapy.
    Borba EF, Bonfá E.
    J Rheumatol; 2001 Apr; 28(4):780-5. PubMed ID: 11327250
    [Abstract] [Full Text] [Related]

  • 10. The complex nature of the interaction between disease activity and therapy on the lipid profile in patients with pediatric systemic lupus erythematosus.
    Sarkissian T, Beyenne J, Feldman B, Adeli K, Silverman E.
    Arthritis Rheum; 2006 Apr; 54(4):1283-90. PubMed ID: 16575849
    [Abstract] [Full Text] [Related]

  • 11. Antimalarial drugs, systemic lupus erythematosus and pregnancy.
    Parke AL.
    J Rheumatol; 1988 Apr; 15(4):607-10. PubMed ID: 3397970
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The efficacy of antimalarials in systemic lupus erythematosus.
    Esdaile JM.
    Lupus; 1993 Feb; 2 Suppl 1():S3-8. PubMed ID: 8485568
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Cytokine polymorphisms influence treatment outcomes in SLE patients treated with antimalarial drugs.
    López P, Gómez J, Mozo L, Gutiérrez C, Suárez A.
    Arthritis Res Ther; 2006 Feb; 8(2):R42. PubMed ID: 16507146
    [Abstract] [Full Text] [Related]

  • 19. Steroid-sparing effects of methotrexate in systemic lupus erythematosus: a double-blind, randomized, placebo-controlled trial.
    Fortin PR, Abrahamowicz M, Ferland D, Lacaille D, Smith CD, Zummer M, Canadian Network For Improved Outcomes in Systemic Lupus.
    Arthritis Rheum; 2008 Dec 15; 59(12):1796-804. PubMed ID: 19035431
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.